IP Library Granted Patent US 12,285,539
Granted Patent B2
US 12,285,539 · App. 17/233,101 · Granted Apr 29, 2025

Hemostatic compositions and related methods

Inventors: Lauren Lydecker (Millbury, MA); Poorva Rajguru (Shoreview, MN); David Wulfman (Minneapolis, MN); Joseph Rausa (Littleton, MA)
Assignee: Boston Scientific Scimed, Inc.
A61L26/0023A61L26/0076A61L26/0085C08K3/011C08K3/32C08L5/08A61L2400/04C08K2003/324
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,285,539
App. No.
17/233,101
Granted
Apr 29, 2025
Kind
B2
Abstract

Compositions including a plurality of particles that may be prepared from a chitosan salt and methods for preparing the same. The plurality of particles may have an average diameter ranging from about 100 μm to about 750 μm, such as from about 150 μm to about 500 μm; a steepness value ranging from about 30 to about 90; and an average aspect ratio greater than 0.6. The plurality of particles may be substantially spherical in shape, for example. Methods of preparation include electrospraying a chitosan salt solution through a needle.

Claims (18)

1. A method of preparing a composition, the method comprising:

electrospraying a solution consisting essentially of a chitosan salt through a needle into an aqueous solution comprising a crosslinking agent to produce a plurality of particles comprising chitosan and the crosslinking agent; and

freeze drying the plurality of particles;

wherein the solution has a viscosity at 25° C. ranging from about 1,500 cPs to about 8,000 cPs; wherein the crosslinking agent comprises tripolyphosphate; wherein the plurality of particles have an average diameter ranging from about 100 μm to about 750 μm and an average aspect ratio ranging from about 0.6 to 1.0; and wherein the plurality of particles has a porosity greater than 80%, as measured by mercury intrusion porosimetry.

2. The method of claim 1 , wherein the chitosan salt is chitosan acetate, chitosan lactate, chitosan succinate, chitosan glutamate, chitosan glycolate, or chitosan citrate.

3. The method of claim 1 , wherein the average diameter of the plurality of particles ranges from about 400 μm to about 600 μm.

4. The method of claim 1 , wherein the average aspect ratio of the plurality of particles ranges from about 0.8 to 1.0.

5. The method of claim 1 , wherein the plurality of particles has a steepness value ranging from about 30 to about 90.

6. The method of claim 1 , wherein the plurality of particles are substantially spherical in shape.

7. The method of claim 1 , wherein the plurality of particles have an average diameter ranging from about 300 μm to about 750 μm and a bulk density ranging from about 0.1 g/mL to about 0.7 g/mL.

8. The method of claim 1 , wherein the electrospraying includes applying a voltage of about 10 kV to about 30 KV to the needle.

9. The method of claim 1 , wherein the needle is a 23 gauge needle.

10. The method of claim 1 , wherein the solution comprises from about 0.5% to about 10% by weight chitosan, based on a volume of the solution.

11. A method of preparing a composition, the method comprising:

electrospraying a solution comprising a chitosan salt through a needle into an aqueous solution comprising a crosslinking agent to produce a plurality of particles consisting essentially of chitosan and the crosslinking agent; and

freeze drying the plurality of particles;

wherein the solution has a viscosity at 25° C. ranging from about 1,500 cPs to about 8,000 cPs; wherein the crosslinking agent comprises tripolyphosphate; wherein the plurality of particles have an average diameter ranging from about 300 μm to about 750 μm, an average aspect ratio ranging from about 0.6 to 1.0, and a bulk density ranging from about 0.1 g/ml to about 0.7 g/ml; and wherein the plurality of particles has a porosity greater than 80%, as measured by mercury intrusion porosimetry.

12. The method of claim 11 , wherein the composition is in the form of a powder.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2021
From: LYDECKER, LAUREN; RAJGURU, POORVA; WULFMAN, DAVID; RAUSA, JOSEPH
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 057654/0804 →
Continuity (2)
Provisional Application 63011492 · Apr 17, 2020
Related Publication 20210322629A1 · Oct 21, 2021
References Cited (201)
US 471854A · Howard · 1892 [cited by applicant]
US 881238A · Hasbrouck · 1908 [cited by applicant]
US 1145520A · Smith · 1915 [cited by applicant]
US 1599959A · Buheiji · 1926 [cited by applicant]
US 1732566A · McKendrick · 1929 [cited by applicant]
US 2151418A · Bolté · 1939 [cited by applicant]
US 2185927A · Shelanski · 1940 [cited by applicant]
US 2478715A · Schmitt · 1949 [cited by applicant]
US 2623519A · Cohen · 1952 [cited by applicant]
US 3669113A · Altounyan et al. · 1972 [cited by applicant]
US 3940061A · Gimple et al. · 1976 [cited by applicant]
US 4184258A · Barrington et al. · 1980 [cited by applicant]
US 4427450A · Kostansek · 1984 [cited by applicant]
US 4457329A · Werley et al. · 1984 [cited by applicant]
US 4806167A · Raythatha · 1989 [cited by applicant]
US 5215221A · Dirksing · 1993 [cited by applicant]
US 5231983A · Matson et al. · 1993 [cited by applicant]
US 5273531A · Knoepfler · 1993 [cited by applicant]
US 5312331A · Kneopfler · 1994 [cited by applicant]
US 5312333A · Churinetz et al. · 1994 [cited by applicant]
US 5366122A · Guentert et al. · 1994 [cited by applicant]
US 5445612A · Terakura et al. · 1995 [cited by applicant]
US 5470311A · Setterstrom et al. · 1995 [cited by applicant]
US 5884621A · Matsugi et al. · 1999 [cited by applicant]
US 5951531A · Ferdman et al. · 1999 [cited by applicant]
US 6003512A · Gerde · 1999 [cited by applicant]
US 6060461A · Drake · 2000 [cited by examiner]
US 6484750B1 · Foos et al. · 2002 [cited by applicant]
US 6554022B2 · Wakeman · 2003 [cited by applicant]
US 6589087B2 · Mackal et al. · 2003 [cited by applicant]
US 6684917B2 · Zhu et al. · 2004 [cited by applicant]
US 6708712B2 · Wakeman · 2004 [cited by applicant]
US 6716190B1 · Glines et al. · 2004 [cited by applicant]
US 6799571B1 · Hughes et al. · 2004 [cited by applicant]
US 7178547B2 · Mackal · 2007 [cited by applicant]
US 7311270B2 · Kapila · 2007 [cited by applicant]
US 7334598B1 · Hollars · 2008 [cited by applicant]
US 7361300B2 · Kelly et al. · 2008 [cited by applicant]
US 7427607B2 · Suzuki · 2008 [cited by applicant]
US 7455248B2 · Kablik et al. · 2008 [cited by applicant]
US 7461649B2 · Gamard et al. · 2008 [cited by applicant]
US 7544177B2 · Gertner · 2009 [cited by applicant]
US 7563299B2 · Baptista da Costa et al. · 2009 [cited by applicant]
US 7673647B2 · Mackal · 2010 [cited by applicant]
US 7841338B2 · Dunne et al. · 2010 [cited by applicant]
US 7892205B2 · Palasis et al. · 2011 [cited by applicant]
US 7921874B2 · Tekulve et al. · 2011 [cited by applicant]
US 8037880B2 · Zhu et al. · 2011 [cited by applicant]
US 8097071B2 · Burgess et al. · 2012 [cited by applicant]
US 8118777B2 · Ducharme et al. · 2012 [cited by applicant]
US 8269058B2 · McCarthy et al. · 2012 [cited by applicant]
US 8313474B2 · Campbell et al. · 2012 [cited by applicant]
US 8360276B2 · Rogier et al. · 2013 [cited by applicant]
US 8361054B2 · Ducharme et al. · 2013 [cited by applicant]
US 8496189B2 · Lomond et al. · 2013 [cited by applicant]
US 8673065B2 · Burgess et al. · 2014 [cited by applicant]
US 8721582B2 · Ji · 2014 [cited by applicant]
US 8728032B2 · Ducharme et al. · 2014 [cited by applicant]
US 8741335B2 · McCarthy · 2014 [cited by applicant]
US 8827980B2 · Ji · 2014 [cited by applicant]
US 8910627B2 · Iwatschenko et al. · 2014 [cited by applicant]
US 8951565B2 · McCarthy · 2015 [cited by applicant]
US 9028437B2 · Ott et al. · 2015 [cited by applicant]
US 9089658B2 · Dunne et al. · 2015 [cited by applicant]
US 9101744B2 · Ducharme · 2015 [cited by applicant]
US 9107668B2 · Melsheimer et al. · 2015 [cited by applicant]
US 9132206B2 · McCarthy · 2015 [cited by applicant]
US 9204957B2 · Gregory et al. · 2015 [cited by applicant]
US 9205170B2 · Lucchesi et al. · 2015 [cited by applicant]
US 9205207B2 · Ji · 2015 [cited by applicant]
US 9205240B2 · Greenhalgh et al. · 2015 [cited by applicant]
US 9308584B2 · Burgess et al. · 2016 [cited by applicant]
US 9310812B2 · Costle et al. · 2016 [cited by applicant]
US 9375533B2 · Ducharme et al. · 2016 [cited by applicant]
US 9492646B2 · Hoogenakker et al. · 2016 [cited by applicant]
US 9517976B2 · Mackal · 2016 [cited by applicant]
US 9545490B2 · Iwatschenko et al. · 2017 [cited by applicant]
US 9555185B2 · Foster et al. · 2017 [cited by applicant]
US 9629966B2 · Ji · 2017 [cited by applicant]
US 9636470B2 · Pohlmann et al. · 2017 [cited by applicant]
US 9707359B2 · Kubo · 2017 [cited by applicant]
US 9713682B2 · Eistetter et al. · 2017 [cited by applicant]
US 9717897B2 · Rogier · 2017 [cited by applicant]
US 9821084B2 · Diegelmann et al. · 2017 [cited by applicant]
US 9839772B2 · Ducharme · 2017 [cited by applicant]
US 9839774B2 · Bonaldo · 2017 [cited by applicant]
US 9846439B2 · Carman et al. · 2017 [cited by applicant]
US 9867931B2 · Gittard · 2018 [cited by applicant]
US 9976660B2 · Stanton et al. · 2018 [cited by applicant]
US 10004690B2 · Lee et al. · 2018 [cited by applicant]
US 10010705B2 · Greenhalgh et al. · 2018 [cited by applicant]
US 10017231B2 · Fawcett, Jr. · 2018 [cited by applicant]
US 10036617B2 · Mackal · 2018 [cited by applicant]
US 10065004B2 · Eder et al. · 2018 [cited by applicant]
US 10173019B2 · Kaufmann et al. · 2019 [cited by applicant]
US 10384049B2 · Stanton et al. · 2019 [cited by applicant]
US 10463811B2 · Lee et al. · 2019 [cited by applicant]
US 10507293B2 · Goodman et al. · 2019 [cited by applicant]
US 10646706B2 · Rogier · 2020 [cited by applicant]
US 10730595B2 · Fawcett · 2020 [cited by applicant]
US 10751523B2 · Rogier · 2020 [cited by applicant]
US 10806853B2 · Gittard · 2020 [cited by applicant]
US 10850814B2 · Fawcett · 2020 [cited by applicant]
US 10994818B2 · Hernandez · 2021 [cited by applicant]
US 20040107963A1 · Finlay et al. · 2004 [cited by applicant]
US 20040249359A1 · Palasis et al. · 2004 [cited by applicant]
US 20050121025A1 · Gamard et al. · 2005 [cited by applicant]
US 20050147656A1 · McCarthy et al. · 2005 [cited by applicant]
US 20050220721A1 · Kablik et al. · 2005 [cited by applicant]
US 20060004314A1 · McCarthy et al. · 2006 [cited by applicant]
US 20060213514A1 · Price et al. · 2006 [cited by applicant]
US 20070056586A1 · Price et al. · 2007 [cited by applicant]
US 20070066920A1 · Hopman et al. · 2007 [cited by applicant]
US 20070066924A1 · Hopman et al. · 2007 [cited by applicant]
US 20070082023A1 · Hopman et al. · 2007 [cited by applicant]
US 20070125375A1 · Finlay et al. · 2007 [cited by applicant]
US 20070151560A1 · Price et al. · 2007 [cited by applicant]
US 20070083137A1 · Hopman et al. · 2007 [cited by applicant]
US 20070199824A1 · Hoerr et al. · 2007 [cited by applicant]
US 20080021374A1 · Kawata · 2008 [cited by applicant]
US 20080287907A1 · Gregory et al. · 2008 [cited by applicant]
US 20090101144A1 · Gamard et al. · 2009 [cited by applicant]
US 20090155342A1 · Diegemann et al. · 2009 [cited by applicant]
US 20090281486A1 · Ducharme · 2009 [cited by applicant]
US 20100121261A1 · Kablik et al. · 2010 [cited by applicant]
US 20100172958A1 · Lucchesi · 2010 [cited by examiner]
US 20100305505A1 · Ducharme et al. · 2010 [cited by applicant]
US 20110073200A1 · Overvaag et al. · 2011 [cited by applicant]
US 20110274726A1 · Guo et al. · 2011 [cited by applicant]
US 20110308516A1 · Price et al. · 2011 [cited by applicant]
US 20130316974A1 · Wang · 2013 [cited by examiner]
US 20140271491A1 · Gittard et al. · 2014 [cited by applicant]
US 20150094649A1 · Gittard · 2015 [cited by applicant]
US 20150125513A1 · McCarthy · 2015 [cited by applicant]
US 20160375202A1 · Goodman et al. · 2016 [cited by applicant]
US 20170035929A1 · Phillips et al. · 2017 [cited by applicant]
US 20170106181A1 · Bonaldo et al. · 2017 [cited by applicant]
US 20170232141A1 · Surti et al. · 2017 [cited by applicant]
US 20170252479A1 · Ji et al. · 2017 [cited by applicant]
US 20170296760A1 · Lee et al. · 2017 [cited by applicant]
US 20170326275A1 · Lecler et al. · 2017 [cited by applicant]
US 20180000737A1 · Bertonis et al. · 2018 [cited by applicant]
US 20180099088A1 · Gittard · 2018 [cited by applicant]
US 20180193574A1 · Smith et al. · 2018 [cited by applicant]
US 20180214160A1 · Hoskins et al. · 2018 [cited by applicant]
US 20180339144A1 · Greenhalgh et al. · 2018 [cited by applicant]
US 20190134366A1 · Erez et al. · 2019 [cited by applicant]
US 20190217315A1 · Maguire et al. · 2019 [cited by applicant]
US 20190232030A1 · Pic et al. · 2019 [cited by applicant]
US 20210024187A1 · Fawcett et al. · 2021 [cited by applicant]
US 20210069485A1 · Rogier · 2021 [cited by applicant]
CN 102172498A · 2011 [cited by applicant]
CN 101401956B · 2012 [cited by applicant]
CN 105903064A · 2016 [cited by applicant]
DE 60215438T2 · 2007 [cited by applicant]
EP 3052168B1 · 2019 [cited by applicant]
JP H07118305A · 1995 [cited by applicant]
WO 03013552A1 · 2003 [cited by applicant]
WO 2004066806A2 · 2004 [cited by applicant]
WO 2005062896A2 · 2005 [cited by applicant]
WO 2006071649A2 · 2006 [cited by applicant]
WO 2006088912A2 · 2006 [cited by applicant]
WO 2008033462A2 · 2008 [cited by applicant]
WO 2009061409A1 · 2009 [cited by applicant]
WO 2015050814A1 · 2015 [cited by applicant]
WO WO2018049310A1 · 2018 [cited by examiner]
WO 2018157772A1 · 2018 [cited by applicant]
Biranje, Santosh S., et al. “Hemostasis and anti-necrotic activity of wound-healing dressing containing chitosan nanoparticles.” International journal of biological macromolecules 121 (2019): 936-946. (Year: 2019). [cited by examiner]
Maeng et al. Journal of Biomedical Materials Research Part A: An Official Journal of The Society for Biomaterials, The Japanese Society for Biomaterials, and The Australian Society for Biomaterials and the Korean Societ… [cited by examiner]
Xu et al. (Journal of microencapsulation 24.2 (2007): 143-151. (Year: 2007). [cited by examiner]
Abyadeh, Morteza, et al. Avicenna journal of medical biotechnology 9.3 (2017): 126. (Year: 2017). [cited by examiner]
Xiong et al. Journal of Microencapsulation 24.2 (2007): 143-151. (Year: 2007). [cited by examiner]
Darwin Microfluidics downloaded on Jan. 11, 2023 from URL :<https://darwin-microfluidics.com/blogs/tools/syringe-needle-gauge-table> 2019. (Year: 2019). [cited by examiner]
Chen et al. J. Mater. Chem. B, 2017, 5, 3686-3696. (Year: 2017). [cited by examiner]
Tapia-Hernandez et al. J. Agric. Food Chem. 2015, 63, 4699-4707. (Year: 2015). [cited by examiner]
Sonnekus, Jolanda. Characterization of the flow and compression properties of chitosan. Diss. North-West University, 2008. (Year: 2008). [cited by examiner]
Songsurang et al. Arch Pharm Res vol. 34, No. 4, 583-592, 2011. (Year: 2011). [cited by examiner]
Kim et al. Carbohydrate Polymers 84 (2011) 1329-1336. (Year: 2011). [cited by examiner]
Bridevaux, Pierre-Olivier, et al. “Short-term safety of thoracoscopic talc pleurodesis for recurrent primary spontaneous pneumothorax: a prospective European multicentre study.” European Respiratory Journal 38.4 (2011):… [cited by applicant]
Giday, Samuel, et al. “Safety analysis of a hemostatic powder in a porcine model of acute severe gastric bleeding.” Digestive diseases and sciences 58.12 (2013): 3422-3428. [cited by applicant]
Giday, Samuel A., et al. “A long-term randomized controlled trial of a novel nanopowder hemostatic agent for control of severe upper gastrointestinal bleeding in a porcine model.” Gastrointestinal Endoscopy 69.5 (2009):… [cited by applicant]
Giday, S. A., et al. “Long-term randomized controlled trial of a novel nanopowder hemostatic agent (TC-325) for control of severe arterial upper gastrointestinal bleeding in a porcine model.” Endoscopy 43.04 (2011): 296… [cited by applicant]
Regalia, Kristen, et al. “Hemospray in Gastrointestinal Bleeding.” Practical Gastroenterology. Endoscopy: Opening New Eyes, ser. 8, May 2014, pp. 13-24. 8. [cited by applicant]
Cook Medical. Hemospray Endoscopic Hemostat, COOK, 2014. (7 pages, in English). [cited by applicant]
“Hemospray Clinical Experience Shows Efficacy of a New Hemostasis Modality—v1”, Cook Medical, 2012. [cited by applicant]
“Hemospray Clinical Experience Shows Efficacy of a New Hemostasis Modality—v2”, Cook Medical, 2013. [cited by applicant]
“Hemospray Clinical Experience Shows Efficacy of a New Hemostasis Modality—v3”, Cook Medical, 2014. [cited by applicant]
Aslanian, Harry R., and Loren Laine. “Hemostatic powder spray for GI bleeding.” Gastrointestinal endoscopy 77.3 (2013): 508-510. [cited by applicant]
Giday, S. A., et al. “Long-term randomized controlled trial of a novel nanopowder hemostatic agent (TC-325) for control of severe arterial upper gastrointestinal bleeding in a porcine model.” Endoscopy 43.04 (2011): 296… [cited by applicant]
Retsch GmbH Haan. Sieve Analysis: Taking a Close Look at Quality, An Expert Guide to Particle Size Analysis. 2015. (56 pages, in English). [cited by applicant]
Micromeritics. Density Analysis, 2001. (6 pages, in English). [cited by applicant]
Micromeritics. “Application Note: Bulk and Skeletal Density Computations for the AutoPore.” May 2012. (3 pages, in English). [cited by applicant]
Arefnia, Ali, et al. “Comparative Study on the Effect of Tire-Derived Aggregate on Specific Gravity of Kaolin.” Electronic Journal of Geotechnical Engineering 18 (2013): 335-44. [cited by applicant]
Kesavan, Jana, et al. “Density Measurements of Materials Used in Aerosol Studies”. Edgewood Chemical Biological Center Aberdeen Proving Ground MD, 2000. [cited by applicant]
Donghong, L et al., “Enhanced Hemostatic Performance Of Tranexamic Acid-Loaded Chitosan/Alginate Composite Microparticles,” [cited by applicant]
Helbling, I.M et al., “Preparation Of TPP-Crosslinked Chitosan Microparticles By Spray Drying For The Controlled Delivery Of Progesterone Intended For Estrus Synchronization In Cattle,” [cited by applicant]
Kumbar, S.G. et al., “Crosslinked Chitosan Microspheres For Encapsulation Of Diclofenac Sodium: Effect Of Crosslinking Agent,” [cited by applicant]
Phromosopha, T. et al., “Chitosan Microparticles Prepared By The Water-In-Oil Emulsion Solvent Diffusion Method For Drug Delivery,” [cited by applicant]
International Search Report in PCT/US2021/027753, dated Jul. 8, 2021 (6 pages). [cited by applicant]
Office Action in Chinese Application No. 202180042885.X, dated Feb. 21, 2024 (9 pages). [cited by applicant]
Communication in European Application No. 21723602.5, dated Feb. 27, 2025 (6 pages). [cited by applicant]